Unknown

Dataset Information

0

Treatment of Diffuse Large B-Cell Lymphoma.


ABSTRACT: Diffuse large B-cell lymphoma (DLBCL) comprises a heterogeneous group with pathophysiological, genetic and clinical features. Many patients can be cured with R-CHOP therapy, which is the current standard regimen. Despite recent progress in improving patient survival, the 40% survival of DLBCL patients remains poor. Therefore, the most important issue for patients with DLBCL remains the development of a new front-line therapy. Several studies have reported that intensified chemotherapy with dose-adjusted EPOCH-R or R-ACVBP was superior to R-CHOP. Gene expression profiling has identified two distinct forms of DLBCL: activated B cell-like (ABC) and germinal center B-cell-like (GCB) types. ABC DLBCL exhibits a worse prognosis than GCB DLBCL by molecular diagnosis after R-CHOP therapy. Next-generation sequencing has identified unique oncogenic mechanisms and genetic complexity, which has provided rational therapeutic targets. There are also a number of biomarkers, including CD5, and prognostic factors. Efforts to distinguish many biomarkers will be crucial for individualized treatment in the future.

SUBMITTER: Miyazaki K 

PROVIDER: S-EPMC6144206 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treatment of Diffuse Large B-Cell Lymphoma.

Miyazaki Kana K  

Journal of clinical and experimental hematopathology : JCEH 20160101 2


Diffuse large B-cell lymphoma (DLBCL) comprises a heterogeneous group with pathophysiological, genetic and clinical features. Many patients can be cured with R-CHOP therapy, which is the current standard regimen. Despite recent progress in improving patient survival, the 40% survival of DLBCL patients remains poor. Therefore, the most important issue for patients with DLBCL remains the development of a new front-line therapy. Several studies have reported that intensified chemotherapy with dose-  ...[more]

Similar Datasets

| S-EPMC8377611 | biostudies-literature
| S-EPMC8502199 | biostudies-literature
| S-EPMC3508519 | biostudies-literature
2002-06-27 | E-GEOD-60 | biostudies-arrayexpress
2002-06-27 | GSE60 | GEO
2021-11-04 | PXD028267 | Pride
| S-EPMC8363059 | biostudies-literature
| S-EPMC10779497 | biostudies-literature
| S-EPMC5487277 | biostudies-other
| S-EPMC6140403 | biostudies-literature